Fig. 4
Molecular characterization of key genes. A Kaplan–Meier curves of PRKCD high and low expression subgroups. B Kaplan–Meier curves of high and low expression groups of UCP2. C Enrichment of GSEA pathways in patients with high and low PRKCD expression using the Hallmark gene set. D Enrichment of GSEA pathways in patients with high and low UCP2 expression using the Hallmark gene set. AUC curve area for ovarian cancer diagnosis using PRKCD (E) and UCP2 (F)